U.S. Recommends Pausing Use Of Johnson & Johnson Vaccine Over Blood Clot Concerns

In a statement on Tuesday, U.S. authorities said they are "reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine."

U.S. Recommends Pausing Use Of Johnson & Johnson Vaccine Over Blood Clot Concerns In a statement on Tuesday, U.S. authorities said they are "reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine." Read More You received this message because you're subscribed to Breaking News Alerts emails. This email was sent by National Public Radio, Inc., 1111 North Capitol Street NE, Washington, DC 20002 Unsubscribe  |  Privacy Policy